Azacitidine Induces Demethylation of the Epstein-Barr Virus Genome in Tumors
Anthony T.�C. Chan(Chinese University of Hong Kong), Richard F. Ambinder(Johns Hopkins University), Qian Tao(Zhejiang University), Philip J. Johnson(Prince of Wales Hospital), Keith D. Robertson(Mayo Clinic), Barbara Klencke, Thomas Wai‐Tong Leung(Chinese University of Hong Kong), Ian W. Flinn(Tennessee Oncology), Risa B. Mann(Boston University), W. H. Kwan(National Institutes of Health)
Cited by 132
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k